Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis
Journal of Clinical Investigation · 01.04.2024 · 134 (7)
DOI: 10.1172/jci179710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2024. Verfasst von Marcella Steffani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Columbia University, New York, New York, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Metabolic dysfunction–associated steatotic liver disease (MASLD) affects nearly 40% of the global adult population and may progress to metabolic dysfunction–associated steatohepatitis (MASH), and MASH-associated liver fibrosis and cirrhosis. Despite numerous studies unraveling the mechanism of hepatic fibrogenesis, there are still no approved antifibrotic therapies. The development of MASLD and liver fibrosis results from complex cell-cell interactions that often initiate within hepatocytes but remain incompletely understood. In this issue of the JCI , Yan and colleagues describe an ATF3/HES1/CEBPA/OPN pathway that links hepatocyte signals to fibrogenic activation of hepatic stellate cells and may provide new perspectives on therapeutic options for MASLD-induced liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Columbia University, New York, New York, USA.
- Institute of Human Nutrition, New York, New York, USA.
- Columbia University Digestive and Liver Disease Research Center, New York, New York, USA.
- Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
Zitieren
APA
Steffani, M., Geng, Y., Pajvani, U. B., & Schwabe, R. F. (2024). Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis. Journal of Clinical Investigation, 134(7). https://doi.org/10.1172/jci179710
Vancouver
Steffani M, Geng Y, Pajvani UB, Schwabe RF. Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis. Journal of Clinical Investigation. 2024;134(7). doi:10.1172/jci179710
BibTeX
@article{Steffani2024,
author = {Steffani, Marcella and Geng, Yana and Pajvani, Utpal B and Schwabe, Robert F},
title = {Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {7},
doi = {10.1172/jci179710}
}
EUVIMED